Talk to us.


Sharing our Point of View is meant to spark a conversation. Let us know what you think.


VCapital at Middle Age

Six years since our first investment in Intensity Therapeutics, VCapital is invested in eleven companies today. Having reached our middle age in “venture capital years,” we are growing increasingly optimistic about our prospects for ultimate maturity.


Reflections on a Career in Venture Capital

A career in venture capital requires an ongoing need to learn and keep learning. After almost four decades in, Len Batterson shares his experience and investment stories.


Venture Capital Investing in an Epoch of Change

The world and everything around us is changing faster than at any time in history. Despite that reality, things rarely feel like they’re changing all that fast, because we are so accustomed to the pace of change.


A Field of Dreams Where Slugging Percentage Matters Most

The key to venture capital investment success is slugging percentage. Doubles and triples are good, but home runs are what really count.


Some Baseballisms for A New Year

With 2021 on deck, our thoughts turn to baseball. Spring training is less than two months away and we hope the pandemic is finally in the bottom of the ninth.


Cleversafe's home run team batting again with Ocient

Cleversafe’s exit, selling to IBM for $1.3 billion, took place in 2015, just as VCapital was starting up. A big idea intersected with practical need and market demand. Many new millionaires were minted as a result.


Conservative Value Investor Takes a Risk

Laws of Attraction: Can conservative value investors love venture capital too? In a word, absolutely.


Venture Capital in a Time of Historic Change

The pandemic’s end remains unknown. Sharing our thoughts on COVID implications for the economy, and especially for venture capital investment, seems in order.


The LoPresti Family: Founders, Investors, and Philanthropists

VCapital is humbled to think of our decade-long relationship with the LoPresti family, as both investors and as friends.


EDJX Profile: Bold Horses Demand World-Class Jockeys

At VCapital, we believe that the jockey can be even more important than the horse. Introducing a key jockey at EDJX, VCapital’s latest portfolio company: James Thomason, the venture’s Chief Technology Officer.


Raydiant Oximetry leaders know how to make it happen.

In the venture capital world, the jockey is often more important than the horse. We look for leader-managers who have proven they can make things happen.


Re-Sorting and Recovery: The Post-COVID U.S. Economy

We believe opportunities to build wealth through venture capital will continue largely unabated because venture capital is all about innovation.


Live CEO Interview: New Developments at SentiAR

Summary of SentiAR’s progress and why it might matter to you. Watch our live interview with CEO Berk Tas.


Aligning with the Anticipated "New Normal"

Managing through the COVID era, our work at VCapital continues.


SentiAR expands to support COVID-19 patients.

An update from SentiAR CEO Berk Tas


Rationality is returning to financial markets.

Chicken Little proven wrong again. The sky isn’t falling after all.


We are staying the course for our investors.

Not out of the woods yet, but the sky does not appear to be falling.


Keeping you informed about your investments.

Our plan is to communicate to you what is most relevant to your relationship with VCapital and your investments.


Unicorns: Bigger is Not Always Better

2020 began with clouds on the horizon.